<bill session="119" type="s" number="1414" updated="2025-06-23T20:11:13Z">
  <state datetime="2025-04-10">REFERRED</state>
  <status>
    <introduced datetime="2025-04-10"/>
  </status>
  <introduced datetime="2025-04-10"/>
  <titles>
    <title type="display">Expedited Access to Biosimilars Act</title>
    <title type="short" as="introduced">Expedited Access to Biosimilars Act</title>
    <title type="official" as="introduced">A bill to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy.</title>
  </titles>
  <sponsor bioguide_id="P000603"/>
  <cosponsors>
    <cosponsor bioguide_id="L000577" joined="2025-06-03"/>
  </cosponsors>
  <actions>
    <action datetime="2025-04-10">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2025-04-10" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
</bill>
